logo-loader
viewBraveheart Investment Group

Braveheart Investment says things get rolling on Kirkstall coronavirus projects initiative

Animal Free Research UK, the UK's leading non-animal medical research charity, is awarding grants to research scientists who will use Kirkstall's Quasi Vivo system in research related to the coronavirus

Braveheart Investment Group -

Braveheart Investment Group PLC (LON:BRH) said things are starting to roll in the collaboration between Kirkstall, its investee company, and Animal Free Research UK.

The non-animal medical research charity has awarded the first three projects that will use Kirkstall's Quasi Vivo system in research related to the coronavirus (COVID-19).

Imperial College London will be modelling early immune responses to SARS-CoV-2 in a fluidic system; the Centre for Sport, Exercise and Life Sciences at Coventry University will investigate obesity, diabetes and COVID-19; and the Johns Hopkins Bloomberg School of Public Health will look into the susceptibility of chronic obstructive pulmonary disease (COPD) and cigarette smoke airway epithelia to SARS-CoV-2.

Quick facts: Braveheart Investment Group

Price: 13.25 GBX

AIM:BRH
Market: AIM
Market Cap: £4.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Braveheart's Trevor Brown details investment in 'exciting' Pharm2Farm Limited

Proactive London's Andrew Scott speaks to Braveheart Investment Group PLC's (LON:BRH) and Pharm2Farm Limited's (P2F) Gareth Cave following Braveheart's investment in the business. P2F has developed a patented process to increase the bioavailability of trace minerals in plant feeds for...

on 15/7/19

2 min read